Results 71 to 80 of about 29,238 (215)

Pneumocystis Pneumonia (PCP) in HIV and AIDS Patients with Pulmonary Symptom [PDF]

, 2012
PCP is one of the most common opportunistic infection in HIV and AIDS patients. A definitive diagnosis of PCP in HIV and AIDS patients in Dr. Soetomo General Hospital Surabaya has not been previously done.
Prasetyo, R. Heru
core  

Pneumocystis jirovecii pneumonia in a non-small cell lung cancer patient on chemoradiotherapy: A case report

Saudi Journal of Medicine and Medical Sciences, 2020
Pneumocystis jirovecii pneumonia is a very uncommon complication in lung cancer patients. We report the case of a 59-year-old, Stage IIIB non-small cell lung cancer (epidermoid) patient who was receiving concurrent chemotherapy scheme (cisplatin ...
Kevin Doello, Víctor Amezcua, Javier García, Javier Valdivia   +3 more
doaj   +1 more source

Efficacy and safety of elranatamab in patients with relapsed or refractory multiple myeloma: A US subgroup analysis from MagnetisMM‐3

Cancer, Volume 132, Issue 11, 1 June 2026.
Abstract Introduction Elranatamab, approved for relapsed or refractory multiple myeloma, demonstrated deep, durable responses and manageable safety in patients without prior B‐cell maturation antigen (BCMA)‐directed therapy (BCMA‐naive) in MagnetisMM‐3 (NCT04649359). This post hoc analysis evaluated efficacy and safety in the US subgroup.
Ajay K. Nooka, Christopher Strouse, Sarah M. Larson, Alexander Lesokhin, Asya Varshavsky‐Yanovsky, David H. Vesole, Guenther Koehne, Elpitha Soussou, Sharon T. Sullivan, Jay Cheng, Noopur Raje   +10 more
wiley   +1 more source

Pneumocystis colonisation is common among hospitalised HIV infected patients with non-Pneumocystis pneumonia

, 2008
Background:When Pneumocystis DNA is recovered from respiratory specimens of patients without Pneumocystis pneumonia (PCP), patients are said to be colonised with Pneumocystis, although the significance of this state is unknown. Understanding risk factors
Welsh, D A, Beard, C B, Charbonnet, D, Swartzman, A, Morris, A, Davis, J L, Crothers, K, Huang, L, Jones, J L, Lawrence, G G, Fox, M R   +10 more
core   +1 more source

Case Report: Synchronous Manifestations of Kaposi Sarcoma Herpesvirus‐Associated Disorders

Cancer Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background Kaposi sarcoma herpes virus (KSHV) is associated with multiple clinical manifestations, including primary effusion lymphoma, an aggressive CD38+ B cell lymphoma with a plasmablastic phenotype. Case This case describes an antiretroviral therapy‐adherent person with HIV who presented with concurrent KSHV‐related disorders of Kaposi ...
Kandice Roberts, Paula Valiño Ramos, Saurabh Jindal, Vikas Prasad, Yi Shan Lee, Mariam Khanfar, Obi L. Griffith, Malachi Griffith, Jeanne Jiang, Ethel Cesarman, Daniel Rauch, Paul Simonson, Thomas Odeny, Lee Ratner   +13 more
wiley   +1 more source

Standardized Management Pathway to Prevent Acute Rejection After Liver Transplantation Following ICI Therapy for Downstaging HCC

Health Care Science, Volume 5, Issue 3, Page 196-206, June 2026.
Findings indicate that within a standardized clinical pathway integrating structured immunosuppression, therapeutic drug monitoring, and early complication surveillance, liver transplantation after ICI exposure can be performed safely without increased rejection risk.
Ning Wang, Zebin Zhu, Hao Zheng, Can Qi, Xiaodong Yuan, Xuefeng Li, Zhijun Xu, Jiwei Qin, Wei Wu, Jizhou Wang, Ruipeng Song, Zhiyong Guo, Lianxin Liu, Shu‐Geng Zhang, Björn Nashan   +14 more
wiley   +1 more source

Teclistamab in relapsed/refractory light chain amyloidosis: A retrospective multicenter study by the German Society for Amyloid Diseases

HemaSphere, Volume 10, Issue 6, June 2026.
Abstract Systemic light chain (AL) amyloidosis is a rare, acquired protein misfolding disorder characterized by extracellular deposition of misfolded immunoglobulin light chain fibrils, resulting in organ damage. Treatment is based on anti‐plasma cell regimens derived from multiple myeloma therapy.
Alexander Carpinteiro, Christoph Kimmich, Despina Trajanova, Ute Hegenbart, Timon Hansen, Udo Holtick, Vera von Landenberg‐Roberg, Stephan Rainer Bohl, Raphael Teipel, Ivana von Metzler, Monika Engelhardt, Evgenii Shumilov, Maximilian Steinhardt, Hans Christian Reinhardt, Sara Oubari, Stefan Schönland   +15 more
wiley   +1 more source

Limited asymptomatic carriage of Pneumocystis jiroveci in human immunodeficiency virus-infected patients

, 2003
Forty-seven bronchoalveolar lavage fluid samples from 16 human immunodeficiency virus (HIV)-infected patients were used to test the latency model of Pneumocystis infection in the human host.
Denis, CM, Wakefield, AE, Ambrose, HE, Lindley, AR, Miller, RF   +4 more
core  

Immune responses of different hosts to Pneumocystis infection

European Respiratory Review
Pneumocystis pneumonia constitutes a critical life-threatening opportunistic infection, where the host's immune response plays a central role in its pathogenesis.
Jun Li, Xiangdong Mu, Haichao Li, Xinmin Liu   +3 more
doaj   +1 more source

Pneumocystis Pneumonia: Immunity, Vaccines, and Treatments

, 2021
For individuals who are immunocompromised, the opportunistic fungal pathogen Pneumocystis jirovecii is capable of causing life-threatening pneumonia as the causative agent of Pneumocystis pneumonia (PCP). PCP remains an acquired immunodeficiency disease (
Aaron D. Gingerich, Jarrod J. Mousa, Karen A. Norris   +2 more
core   +1 more source